Glickman Urologic and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Glickman Tower, Cleveland, OH, Q10-218, USA.
World J Urol. 2023 Sep;41(9):2555-2561. doi: 10.1007/s00345-023-04538-1. Epub 2023 Jul 29.
To provide an update on the diverse, contemporary urological applications of the Hugo™ RAS system.
A comprehensive literature review was performed to identify studies that described the clinical applications of the Hugo™ RAS system in Urology. The Hugo™ RAS is a new multi-modular robotic platform created by Medtronic, which offered new innovations, including an open surgical console and individual modular and extendable robotic arms that come in their own movable platforms. Since obtaining regulatory approval in Europe in October 2021, the novel platform has been increasingly used in various urologic and gynecologic procedures.
A total of 10 studies were included, which involved 176 patients who underwent varying urological procedures. These included radical and simple prostatectomy, partial nephrectomy, radical and simple nephrectomy, ureterolithotomy, ureteral reimplant, pyeloplasty, and adrenalectomy. The different docking configurations, operating room set-ups, and early perioperative outcomes were described for the respective procedure.
Based on the existing literature, the Hugo™ RAS system can be safely and effectively utilized for various urological procedures. The novel technology provided additional value in enriching the repertoire of urological minimally invasive surgical options. Further research with larger cohort of patients will be required to better refine the operating techniques and understand the perioperative outcomes of the Hugo™ RAS, especially when compared to other robotic surgical platforms.
提供 Hugo™ RAS 系统在泌尿科的多种当代应用的最新信息。
我们进行了全面的文献回顾,以确定描述 Hugo™ RAS 系统在泌尿科临床应用的研究。Hugo™ RAS 是由美敦力公司创建的新型多模块机器人平台,提供了新的创新,包括开放式手术控制台以及单独的模块化和可扩展的机器人手臂,它们带有自己的可移动平台。自 2021 年 10 月在欧洲获得监管批准以来,该新型平台已越来越多地用于各种泌尿科和妇科手术。
共纳入了 10 项研究,涉及 176 名接受不同泌尿科手术的患者。这些手术包括根治性和单纯性前列腺切除术、部分肾切除术、根治性和单纯性肾切除术、输尿管切开取石术、输尿管再植术、肾盂成形术和肾上腺切除术。分别描述了各自手术的不同对接配置、手术室设置和早期围手术期结果。
根据现有文献,Hugo™ RAS 系统可安全有效地用于各种泌尿科手术。这项新技术在丰富泌尿科微创手术选择方面提供了额外的价值。需要进一步研究更多患者的队列,以更好地完善 Hugo™ RAS 的手术技术和了解其围手术期结果,特别是与其他机器人手术平台相比时。